Industry Wire 213

September 25, 2024 Jake Fishman 0 min read
  1. Novo Nordisk CEO testifies on Capitol Hill over high GLP-1 costs.
  2. Particle Health sues Epic for violating antitrust laws.
  3. Smaller companies consider having employees get their own health plans.
  4. One in seven scientific papers may be at least partly fake.
  5. Santa Clara county to acquire HCA hospital, make it public.
  6. Four ways to keep physicians from quitting.
  7. NJ might penalize HCPs for spreading healthcare misinformation.
  8. California bans medical debt from credit reports.
  9. Harvard Med researchers use AI to match existing drugs with rare diseases.
  10. Penn Medicine residents and fellows reach tentative labor deal.
Get twice-weekly insights on the biggest stories shaping cardiology.

You might also like

Cardiology Practices September 18, 2025

What Cardiologists Say vs. What Patients Hear September 18, 2025

Cardiovascular risk communication might be failing patients when they need it most, after the HARIPA study revealed significant disconnects between patient and physician perceptions of future cardiovascular risk and procedural complications. The HARIPA study surveyed cardiology inpatients and their physicians from October 2022 to March 2023, using structured questionnaires to assess risk perception and communication […]

Digital Health September 15, 2025

TRICORDER Shows Potential of AI Stethoscopes September 15, 2025

Results from the massive TRICORDER study suggest Eko Health’s AI-powered stethoscopes could change the way primary care providers perform cardiac screening, potentially catching thousands more patients for cardiologists to treat. The TRICORDER study results encompassed 205 NHS GP practices over 12 months, with nearly 1,000 providers performing more than 12.8k AI-stethoscope exams in routine care […]

ASE 2025

Cardiology September 11, 2025

Cardiac Wire’s ASE 2025 Takeaways September 11, 2025

The American Society of Echocardiography left an echo this year in Music City as it celebrated its 50th year. Among the studies and products unveiled at ASE 2025, here are Cardiac Wire’s top five takeaways from the meeting. Premium Echo Has Found its Stride – Although most typically think of ultrasound as a lower cost […]